MoneyWorks4Me

Makers Laboratories - Quaterly Results

23 May 2024 Evaluate
A fair growth of 5.64% in the revenue at Rs. 114.53 millions was reported in the March 2024 quarter as compared to Rs. 108.42 millions during year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -15.57 millions as compared to Net Loss of Rs. -8.05 millions of corresponding quarter ended March 2023Operating profit for the quarter ended March 2024 rose to 0.08 millions as compared to 0.03 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 114.53 108.42 5.64 490.89 425.47 15.38 490.89 425.47 15.38
Other Income 1.48 1.79 -17.32 11.52 11.37 1.32 11.52 11.37 1.32
PBIDT 0.08 0.03 166.67 -26.09 -29.97 -12.95 -26.09 -29.97 -12.95
Interest 4.61 2.82 63.48 16.34 13.81 18.32 16.34 13.81 18.32
PBDT -4.53 -2.79 62.37 -42.43 -43.78 -3.08 -42.43 -43.78 -3.08
Depreciation 6.83 6.55 4.27 27.15 23.99 13.17 27.15 23.99 13.17
PBT -11.36 -9.34 21.63 -69.58 -67.77 2.67 -69.58 -67.77 2.67
TAX 4.21 -1.29 -426.36 -0.06 -4.15 -98.55 -0.06 -4.15 -98.55
Deferred Tax 4.23 -1.44 -393.75 -0.04 -4.30 -99.07 -0.04 -4.30 -99.07
PAT -15.57 -8.05 93.42 -69.52 -63.62 9.27 -69.52 -63.62 9.27
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 59.00 0.00
PBIDTM(%) 0.07 0.03 152.35 -5.31 -7.04 -24.55 -5.31 -7.04 -24.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..